Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eurivit-M
- Development stage
- Unknown
- Lead developer
- Eurocare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Eurivit-M is an over-the-counter multivitamin and mineral supplement developed by Eurocare and manufactured by AM-Europharma in the Philippines. It is formulated as a sugar-coated tablet containing a comprehensive blend of essential water-soluble and fat-soluble vitamins (including Vitamin A, Vitamin D, Vitamin E, Vitamin C, and Vitamin B complex) along with essential minerals (such as Calcium, Iron, Magnesium, Potassium, Manganese, and Zinc). Eurivit-M is indicated for the prophylaxis and treatment of vitamin and mineral deficiencies, particularly in cases of inadequate nutrition, increased physical activity, recovery from illness, or high stress.
- Brand names
- Eurivit-M
- Other names
- multivitamins + mineralsmultivitamins and minerals
02
Targets
RXR (RXR family)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Eurivit-M.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eurivit-M.